Clinical Trial Update: A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating MHB036C in combination with MHB039A in patients with advanced breast cancer or other advanced ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumor

Drugs mentioned

• MHB036C
• MHB039A

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Advanced Breast Cancer, Advanced Malignant Solid Tumor | Phase 2 | Status: RECRUITING